Ca2+ Dyshomeostasis Disrupts Neuronal and Synaptic Function in Alzheimer’s Disease
Open accessThe DOI matches its Crossref record; 242 of the 243 references it cites were found in a registry or an index.
Abstract
Ca2+ homeostasis is essential for multiple neuronal functions and thus, Ca2+ dyshomeostasis can lead to widespread impairment of cellular and synaptic signaling, subsequently contributing to dementia and Alzheimer’s disease (AD). While numerous studies implicate Ca2+ mishandling in AD, the cellular basis for loss of cognitive function remains under investigation. The process of synaptic degradation and degeneration in AD is slow, and constitutes a series of maladaptive processes each contributing to a further destabilization of the Ca2+ homeostatic machinery. Ca2+ homeostasis involves precise maintenance of cytosolic Ca2+ levels, despite extracellular influx via multiple synaptic Ca2+ channels, and intracellular release via organelles such as the endoplasmic reticulum (ER) via ryanodine receptor (RyRs) and IP3R, lysosomes via transient receptor potential mucolipin channel (TRPML) and two pore channel (TPC), and mitochondria via the permeability transition pore (PTP). Furthermore, functioning of these organelles relies upon regulated inter-organelle Ca2+ handling, with aberrant signaling resulting in synaptic dysfunction, protein mishandling, oxidative stress and defective bioenergetics, among other consequences consistent with AD. With few effective treatments currently available to mitigate AD, the past few years have seen a significant increase in the study of synaptic and cellular mechanisms as drivers of AD, including Ca2+ dyshomeostasis. Here, we detail some key findings and discuss implications for future AD treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Synergistic Ca2+ interactions between RyR and glutamatergic synaptic transmission in AD mouse cortical neurons. (A) Pseudocolored images of relative Ca2+ changes in representative NonTg (top), TAS/TPM (a double transgenic AD mouse model) (middle), and 3xTg-AD (a triple transgenic AD mouse model) (bottom) neurons in the following conditions (from left to right): baseline 30 Hz synaptic stimulation (1.5 s), caffeine alone (10 mm), 30 Hz synaptic stimulation plus caffeine, and washout. (B) Representative Ca2+ response traces after 30 Hz synaptic stimulation (voltage trace shown in top) shown as percentage over baseline, in control aCSF (left panels) and in 10 mM caffeine (right panels) for NonTg (top), TAS/TPM (middle), and 3xTg-AD (bottom) neurons. (C) Bar graphs show averaged (mean ± SE) Ca2+ responses integrated over a 1.5 s time period of 30 Hz synaptic stimulation in control ACSF (left grouping), synaptic stimulation plus caffeine (center), and synaptic stimulation with ryanodine in the pipette (right grouping) for the NonTg, TAS/TPM, and 3xTg-AD neurons. Statistically significant differences are indicated by asterisks (one-way ANOVA, p < 0.05). * Significantly different from NonTg within treatment group; ** significantly different from synaptic stimulation in aCSF within transgenic strain (modified from [9]).](https://figures.cochat.ai/paper-figures/e9cb90741b9e4579b659f44d2690025a/ca2-dyshomeostasis-disrupts-neuronal-and-synaptic-function-in-alzheimers-disease-figure-1.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Complexes formed by Aβ with α7-nAChR efficiently promote Aβ internalization and increased calcium influx, further affecting extracellular Aβ plaque accumulation and synaptic transmission.308”
From Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies. (2024) · cites this paper as [308]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A synaptic model of memory: long-term potentiation in the hippocampus
Bliss, T. V. P., & Collingridge, G. L. (1993) · Nature · doi:10.1038/361031a0 · Cited by 11,566 · cited 1×
“NMDARs in particular are one of the most well characterized postsynaptic glutamate receptors, with a high Ca2+ permeability and an established role in hippocampal synaptic plasticity [17].”
BackgroundAmyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126 · cited 2×
“In addition to effects on basal synaptic transmission, changes in RyR-Ca2+ signaling may also have implications for synaptic plasticity and LTP, which are impaired in AD mice [8,45].”
BackgroundResultMitochondrial membrane permeabilization in cell death
Kroemer, G., Galluzzi, L., & Brenner, C. (2007) · Physiological Reviews · doi:10.1152/physrev.00013.2006 · Cited by 3,598 · cited 1×
“The two functional states of the PTP regulates the amount of Ca2+ released; where the low conductance state amplifies Ca2+ waves and the high conductance state releases a surge of Ca2+ and apoptotic signals such as cytochrome C [180,181].”
BackgroundSELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE
DAVIES, P. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91936-x · Cited by 3,565 · cited 1×
“Cholinergic neurons in particular show significant degeneration in the course of AD [75,76], and this has resulted in development of medications to enhance cholinergic transmission, presumably through the activation of postsynaptic nAChRs.”
Backgroundde Duve, C., & Wattiaux, R. (1966) · Annual Review of Physiology · doi:10.1146/annurev.ph.28.030166.002251 · Cited by 3,033
A Gene Network Regulating Lysosomal Biogenesis and Function
Sardiello, M., Palmieri, M., di Ronza, A., Medina, D. L., Valenza, M., Gennarino, V. A., Di Malta, C., Donaudy, F., Embrione, V., Polishchuk, R. S., et al. (2009) · Science · doi:10.1126/science.1174447 · Cited by 2,543
Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity
DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376
Cited by
Zhang, J., Zhang, Y., Wang, J., Xia, Y., Zhang, J., & Chen, L. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01911-3 · Cited by 1,138
Autophagy–lysosomal-associated neuronal death in neurodegenerative disease
Nixon, R. A. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02799-7 · Cited by 133
Princen, K., Dooren, T. V., van Gorsel, M., Louros, N. N., Yang, X., Dumbacher, M., Bastiaens, I., Coupet, K., Dupont, S., Cuveliers, E., et al. (2024) · Science · doi:10.1126/science.add6260 · Cited by 76
Alkhalifa, A. E., Alkhalifa, O., Durdanovic, I., Ibrahim, D. R., & Maragkou, S. (2025) · Journal of Dementia and Alzheimer's Disease · doi:10.3390/jdad2020017 · Cited by 66
Pathogenesis of sporadic Alzheimer's disease by deficiency of NMDA receptor subunit GluN3A
Zhong, W., Wu, A., Berglund, K., Gu, X., Jiang, M. Q., Talati, J., Zhao, J., Wei, L., & Yu, S. P. (2022) · Alzheimer's & Dementia · doi:10.1002/alz.12398 · Cited by 59
Central nervous system effects of 5-HT7 receptors: a potential target for neurodegenerative diseases
Quintero-Villegas, A., & Valdés‐Ferrer, S. I. (2022) · Molecular Medicine · doi:10.1186/s10020-022-00497-2 · Cited by 53
Guan, P.-P., Cao, L., Yang, Y., & Wang, P. (2021) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2021.757515 · Cited by 53
Webber, E. K., Fivaz, M., Stutzmann, G. E., & Griffioen, G. (2023) · Alzheimer's & Dementia · doi:10.1002/alz.13065 · Cited by 50
Self-citationUrdánoz‐Casado, A., de Gordoa, J. S., Robles, M., Acha, B., Roldán, M., Zelaya, M. V., Blanco‐Luquin, I., & Mendióroz, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179205 · Cited by 47
Liu, W., Li, Y., Zhao, T., Gong, M., Wang, X., Zhang, Y., Xu, L., Li, W., Li, Y., & Jia, J. (2023) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2023.102534 · Cited by 46
Xiang, X., Wang, X., Wu, Y., Hu, J., Li, Y., Jin, S., & Wu, X. G. (2022) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2022.173340 · Cited by 43
Negri, S., Faris, P. S., Tullii, G., Vismara, M., Pellegata, A. F., Lodola, F., Guidetti, G. F., Rosti, V., Antognazza, M. R., & Moccia, F. D. (2021) · Cell Calcium · doi:10.1016/j.ceca.2021.102502 · Cited by 34
[Retracted] A Review of Bile Acid Metabolism and Signaling in Cognitive Dysfunction‐Related Diseases
Weng, Z.-B., Chen, Y.-R., Lv, J.-T., Wang, M.-X., Chen, Z.-Y., Zhou, W., Shen, X.-C., Zhan, L.-B., & Wang, F. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/4289383 · Cited by 32
“In addition, recent studies have revealed that gut microbiota dysregulation [99, 100] and Ca2+ in fl ux [101, 102] are also closely associated with AD.”
RetractedZhang, H., Knight, C., Chen, S. R. W., & Bezprozvanny, I. (2023) · The Journal of Neuroscience · doi:10.1523/jneurosci.1820-22.2022 · Cited by 32
Callens, M., Loncke, J., & Bultynck, G. (2022) · Cells · doi:10.3390/cells11121963 · Cited by 32
Li, Z., Cao, Y., Pei, H., Ma, L., Yang, Y., & Li, H. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1158204 · Cited by 30
Chami, M. (2021) · Cells · doi:10.3390/cells10010140 · Cited by 26
Critical appraisal on mitochondrial dysfunction in Alzheimer’s disease
Ahmad, F., & Sachdeva, P. (2022) · Aging Medicine · doi:10.1002/agm2.12217 · Cited by 23
Lithium Provides Broad Therapeutic Benefits in an Alzheimer’s Disease Mouse Model
Wiseman, A. L., Briggs, C. A., Peritt, A., Kapecki, N., Peterson, D. A., Shim, S. S., & Stutzmann, G. E. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220758 · Cited by 23
Self-citationMa, X., Liu, J., Jiang, L., Gao, Z., Shi, Z., Zhang, N., Wang, Z., Li, S., Zhang, R., & Xu, S. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.140945 · Cited by 23
Javadpour, P., Abbaszadeh, F., Ahmadiani, A., Rezaei, M., & Ghasemi, R. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04009-7 · Cited by 22
Astroglial calcium signaling and homeostasis in tuberous sclerosis complex
Romagnolo, A., Dematteis, G., Scheper, M., Luinenburg, M. J., Mühlebner, A., Hecke, W. V., Manfredi, M., Giorgis, V. D., Reano, S., Filigheddu, N., et al. (2024) · Acta Neuropathologica · doi:10.1007/s00401-024-02711-3 · Cited by 21
Luo, D., Liu, H., Liu, H., Wu, W., Zhu, H., Ge, W., & Ma, C. (2022) · Aging and Disease · doi:10.14336/ad.2022.0607 · Cited by 21
Bir, A., Ghosh, A., Chauhan, A., Saha, S., Saini, A. K., Bisaglia, M., & Chakrabarti, S. (2024) · Antioxidants · doi:10.3390/antiox13030316 · Cited by 20
Laparra, I. C., Juárez‐Escoto, E., Vicario‐Abejón, C., Moratalla, R., & García‐Sanz, P. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1087072 · Cited by 17
Dutta, B. J., Singh, S., Seksaria, S., Gupta, G. D., Bodakhe, S. H., & Singh, A. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.115071 · Cited by 16
Lithium: An Old Drug for New Therapeutic Strategy for Alzheimer’s Disease and Related Dementia
Shim, S. S., Berglund, K., & Yu, S. P. (2023) · Neurodegenerative Diseases · doi:10.1159/000533797 · Cited by 16
Hou, M., Zhang, Z., Fan, Z.-X., Huang, L., & Wang, L. (2024) · Medicine · doi:10.1097/md.0000000000039405 · Cited by 15
Kopeć, K., Koziorowski, D., & Szlufik, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157552 · Cited by 15
Lykhmus, O., Tzeng, W.-Y., Koval, L., Uspenska, K., Zirdum, E., Kalashnyk, O., Garaschuk, O., & Skok, M. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117255 · Cited by 14
Bhuiyan, P., Zhang, W., Liang, G., Jiang, B., Vera, R., Chae, R., Kim, K., Louis, L. S., Wang, Y., Liu, J., et al. (2025) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-025-10185-7 · Cited by 14
Owumi, S. E., Chimezie, J., Salami, M. O., Ishaya, J. A., Chidindu, O. V., Nnamdi, M., & Owoeye, O. (2025) · Toxicon · doi:10.1016/j.toxicon.2025.108345 · Cited by 14
Impact of β-Amyloids Induced Disruption of Ca2+ Homeostasis in a Simple Model of Neuronal Activity
von Bonhorst, F. P., Gall, D., & Dupont, G. (2022) · Cells · doi:10.3390/cells11040615 · Cited by 14
Paschou, M. A., Papazafiri, P., Charalampous, C., Zachariadis, M., Dedos, S., & Doxakis, E. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04398-9 · Cited by 14
Reed, A. L., Mitchell, W., Alexandrescu, A. T., & Alder, N. N. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1263420 · Cited by 13
Berkowitz, B. A., Podolsky, R. H., Childers, K. L., Roberts, R., Katz, R., Waseem, R., Robbings, B. M., Hass, D. T., Hurley, J. B., Sweet, I. R., et al. (2022) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.63.13.22 · Cited by 12
Shi, Z., Sun, J., Dai, X., Ling, P., Chen, H., & Gao, F. (2024) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.4c02803 · Cited by 12
Klingl, Y. E., Petrauskas, A., Jaślan, D., & Grimm, C. M. (2025) · Physiological Reviews · doi:10.1152/physrev.00044.2024 · Cited by 11
Calcium-iron crosstalk in epileptogenesis: Unraveling mechanisms and therapeutic opportunities
Li, X., Tao, A.-L., Wu, N., Zhang, X., Xiao, F., Wang, J., & Wang, Z. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.106989 · Cited by 10
Sun, T., Du, Y.-Y., Zhang, Y., Tian, Q., Li, X., Yu, J., Guo, Y., Liu, Q., Yang, L., Wu, Y., et al. (2024) · ACS Omega · doi:10.1021/acsomega.3c08934 · Cited by 10
Aathira, N. S., Kaur, A., Kumar, A., Dar, G. M., Nimisha, Sharma, A. K., Bera, P., Mahajan, B., Chatterjee, A., & Saluja, S. S. (2025) · Neuroscience · doi:10.1016/j.neuroscience.2025.05.021 · Cited by 10
Fagone, P., Mangano, K., Martino, G., Quattropani, M. C. A., Pennisi, M., Bella, R., Fisicaro, F., Nicoletti, F., & Petralia, M. C. (2022) · Genes · doi:10.3390/genes13040703 · Cited by 10
COVID-19-induced neurological symptoms: focus on the role of metal ions
Zhang, Y., Ren, K., Luo, X., & Peng, J. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01176-2 · Cited by 10
Calcium channel signalling at neuronal endoplasmic reticulum-plasma membrane junctions
Maciąg, F., Chhikara, A., & Heine, M. (2024) · Biochemical Society Transactions · doi:10.1042/bst20230819 · Cited by 10
Berkowitz, B. A., Podolsky, R. H., Childers, K. L., Roberts, R., & Waseem, R. (2023) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.64.3.12 · Cited by 8
Bhuiyan, P., Zhang, W., Chae, R., Kim, K., Louis, L. S., Wang, Y., Liang, G., & Wei, H. (2025) · British Journal of Anaesthesia · doi:10.1016/j.bja.2025.02.018 · Cited by 7
Mutation of TRPML1 Channel and Pathogenesis of Neurodegeneration in Haimeria
Gao, J., Li, H., Lv, H., & Cheng, X. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03874-y · Cited by 6
The Janus face of CaMKII: from memory consolidation to neurotoxic switch in Alzheimer’s disease
Tang, L., Liu, F., Sun, X., Yang, J., Liu, Y., Pan, X., Hao, L., Lou, F., & Su, J. (2025) · Archives of Toxicology · doi:10.1007/s00204-025-04160-7 · Cited by 6
Meher, M. M., Afrin, M., Jahan, M. R., Nozaki, K., Masumoto, K., Yanai, A., & Islam, M. N. (2025) · Acta Histochemica · doi:10.1016/j.acthis.2025.152291 · Cited by 6
Berkowitz, B. A., Paruchuri, A., Stanek, J., Abdul-Nabi, M., Podolsky, R. H., Bustos, A. H., Childers, K. L., Murphy, G. G., Stangis, K. A., & Roberts, R. (2024) · Acta Neuropathologica Communications · doi:10.1186/s40478-024-01799-8 · Cited by 5
A Review on the Pathophysiology of Alzheimer’s Disease
Agarwal, U., Kapoor, G. T., & Tonk, R. K. (2025) · Current Protein and Peptide Science · doi:10.2174/0113892037416859250915091846 · Cited by 5
Neurodegenerative Disease Diagnosis via Ion‐Level Detection in the Brain
Chen, Y., Wei, M., Lee, J., Zhao, J., Lin, P., Wang, Q., Li, F., & Ling, D. (2021) · Advanced NanoBiomed Research · doi:10.1002/anbr.202100007 · Cited by 5
Ali, H., Tofrizal, T., Tjong, D. H., Yanis, A., & Yarni, S. D. (2023) · Archives of Medical Science · doi:10.5114/aoms/163353 · Cited by 5
Alyami, N. M., Alonaizan, R., Alobaid, H. M., Maodaa, S. N., Alothman, N. S., Alshiban, N. M., Alnakhli, Z. H., Alyami, M. M., & Almeer, R. (2025) · Toxicology · doi:10.1016/j.tox.2025.154358 · Cited by 4
Wu, L., Hou, F., Wang, Z., Wu, M., Wang, X., Cao, J., Wang, Y., & Cai, H. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115686 · Cited by 4
Taurine as an Early-Phase Disease-Modifying Candidate for Alzheimer’s Disease
Hossain, M. K., & Kim, H. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27041871 · Cited by 4
MAMs as a promising therapeutic strategy for age-related neurodegenerative diseases
Galizzi, G. (2026) · Aging and Disease · doi:10.14336/ad.2025.1342 · Cited by 4
Vera, R., Hong, N., Jiang, B., Liang, G., Eckenhoff, M. F., Kincaid, H. J., Browne, V., Chellaraj, V., Gisewhite, D. R., Greenberg, M., et al. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231337 · Cited by 4
Zheng, J. J., Antrobus, S., Feng, W., Purdy, T. N., Moore, B. S., & Pessah, I. N. (2021) · Environmental Science & Technology · doi:10.1021/acs.est.1c05214 · Cited by 4
Farindra, I., Soetjipto, Kalanjati, V. P., Rusdi, W. E., Suwito, B. E., Andini, A., Farmananda, I. R., Jannah, R. M., Arafany, F., Ramadhany, R. R., et al. (2024) · Tropical Journal of Natural Product Research · doi:10.26538/tjnpr/v8i9.11 · Cited by 4
Neuronal calcium signaling: Mechanisms, function and clinical implications in neurological diseases
Zhu, W.-L., & Xiao, S.-W. (2025) · New cell · doi:10.61958/ncak9943 · Cited by 3
Konsta, V., Paschou, M. A., Koti, N., Vlachou, M. E., Livanos, P., Xilouri, M., & Papazafiri, P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252111637 · Cited by 3
Saini, S., Kumar, V., Haldar, S., Chauhan, S., Demiwal, P., Ghosh, S., Gupta, S., Sircar, D., Mahajon, B., & Roy, P. (2024) · Phytomedicine Plus · doi:10.1016/j.phyplu.2024.100682 · Cited by 3
Su, J., Wei, J., Zhang, B., Wang, X., Tang, L., Yuan, Y., Sun, X., Qi, S., Yang, J., Xue, Y., et al. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108502 · Cited by 3
Chen, L., Wang, H., & Cheng, Y. (2025) · Chinese Chemical Letters · doi:10.1016/j.cclet.2025.111172 · Cited by 2
Bhatia, N., Khan, M. M. U., Masih, D., & Srinivas, U. (2025) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-025-00318-w · Cited by 2
Jáuregui, G. V., & Parpura, V. (2025) · Ageing & Longevity · doi:10.47855/jal9020-2025-2-3 · Cited by 2
Green, J. W., Fonseca, L. M., Beeri, M. S., Simon, S. S., Parrott, J. S., Ljubic, B., Schulewski, M., Tafuto, B. A., & Gohel, S. (2026) · medRxiv · doi:10.64898/2026.02.06.26345763 · Cited by 2
Yang, H., Matsuhisa, K., Wei, T., Nishi, W., Koh, D. H. Z., Sim, A. Y., Bonne, I., & Saheki, Y. (2026) · Nature Communications · doi:10.1038/s41467-026-77423-1 · Cited by 1
Ryanodex Reduces Persistent Hippocampal Effects of Single Mild Traumatic Brain Injury in Rats
Berlet, R., Bear, I., Kessinger, C., Whitcomb, E., Browne, V., Chellaraj, V., Bailes, J. E., & McDaid, J. (2025) · Neurotrauma Reports · doi:10.1177/08977151251366069
Self-citationTau-Cytoskeleton and their interaction with other neurodegenerative proteins
Sahu, S., Rangappa, N., Chinnathambi, S., & Mishra, M. (2025) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2025.10.032
Ca2+-sensitive Mef2c protein interactions and chromatin function in microglia-like cells
Ballard, C. H. (2022) · ORCA Online Research @Cardiff (Cardiff University)
Roy, K. K., Mehta, D. K., & Das, R. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02178-6
The calm before dSTORM: neuronal RyR2 and its role in Alzheimer’s disease and comorbid epilepsy
Chan, J. A. (2026) · Otago University Research Archive (University of Otago) · doi:10.82348/our-archive.00083
Gul‐Hinc, S., Szutowicz, A., Ronowska, A., & Jankowska-Kulawy, A. (2026) · Cells · doi:10.3390/cells15110960
Bjerke, I. E., Rogulina, O., Overdevest, M. I., Begkai, A. M., Laja, A., Yates, S. C., Kleven, H., Reiten, I., Witter, M. P., & Leergaard, T. B. (2026) · Scientific Data · doi:10.1038/s41597-026-07614-4
Translasyonel Araştırmalarda Hastalık Modelleri ve Analiz Yöntemleri
Alpay, M., Yılmaz, I. T., Özkaraca, M., Mendĭl, A. S., Kaya, Ö., KÖÇKEN, K., Baksi, N., Ekinci, E., Mokhtare, B., Timurkaan, N., et al. (2026) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.4023
Dubrovina, N. I., Ovsyukova, M. V., Gao, V., & Tikhonova, M. A. (2026) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-026-02047-3
Role of Ryanodine Receptor Clustering in Alzheimer’s Disease
Silva, R. V. (2022) · Otago University Research Archive (University of Otago)
Vitamin D Deficiency in Preclinical Medical Students: Neuroendocrine, Cognitive, and Immune Effects
Degard-Edmond, L., & Panta, R. (2026) · Cureus · doi:10.7759/cureus.115944
Calmodulin controls spatial and temporal specificity of calcium-induced calcium release
Jędrzejewska‐Szmek, J., & Blackwell, K. T. (2026) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1013752
Saha, S. (2026) · American journal of student research. · doi:10.70251/hyjr2348.45299312
Zhu, J., Li, J., Li, W., Liu, Y., Shi, Y., Ibrahim, N., Dong, J., & Fan, H. (2026) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2026.112356
林, 栓., Wang, Q., & Cao, J. (2026) · Nature Cell and Science · doi:10.61474/ncs.2026.00024
Sánchez‐Puelles, C., Hernández‐Vivanco, A., Grieco, A., Camacho-Olmos, I., Montero‐Calle, A., López‐Sánchez, N., Fraj, A., Garrido‐García, A., Cano‐Daganzo, V., Lozano-Ureña, A., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.11.13.766444
Metadata
- Authors
- McDaid, J., Mustaly-Kalimi, S., & Stutzmann, G. E.
- Affiliations
- Rosalind Franklin University of Medicine and Science (US)
- Corresponding author
- Stutzmann, Grace E.
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2020-12-10
- Volume
- 9
- Issue
- 12
- Pages
- 2655
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC7763805
- OpenAlex
- W3112777679
- Cited by
- 73
- References
- 243
- Citations by year
- 2026: 9 · 2025: 18 · 2024: 16 · 2023: 11 · 2022: 12 · 2021: 7
- FWCI
- 0.95
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health (NIA AG055497)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Calcium signaling and nucleotide metabolism
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- calcium homeostasis, calcium dyshomeostasis, Alzheimer's disease, synaptic dysfunction, neuronal function, ryanodine receptor, IP3 receptor, TRPML, two-pore channels, mitochondrial permeability transition pore, oxidative stress, bioenergetics, dementia
- MeSH terms
- Alzheimer Disease, Cytosol, Endoplasmic Reticulum, Humans, Neurons, Synapses, Oxidative Stress, Ryanodine Receptor Calcium Release Channel, Calcium Signaling
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.